首页 > 最新文献

Tanaffos最新文献

英文 中文
COVID-19 in Pediatric Patients: An update on Features and Treatment Options. 儿童患者中的COVID-19:最新特征和治疗方案
Q3 Medicine Pub Date : 2022-03-01
Zahra Soheilirad, Pegah Karimian, Motahare Aghajani Delvar

This review aimed to identify the features of coronavirus disease 2019 (COVID-19) in pediatric patients after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. According to the literature, the incidence of COVID-19 was reported to be 1-5% among children. However, the incidence of infection with the new variant of the virus is higher in children. The most common features were fever and respiratory manifestation. The milder severity and lower mortality of COVID-19 among children are related to their less contact, immature immune system, and different features of angiotensin-converting enzyme 2 (ACE2), an important receptor of the virus to invade the host cells. Several complications were observed in severe pediatric patients, such as coinfections, encephalitis, multisystem inflammatory syndrome, and multiorgan failure. The most frequent laboratory data were the procalcitonin elevation. The enhanced inflammatory factors and lymphocytopenia were less common among this population. In the CT findings, the ground-glass opacities, pulmonary consolidation, fine mesh shadow, and tiny nodules were most common. While some children were admitted to the ICU, mechanical ventilation was rarely reported. The vertical intrauterine transmission from mother to child has not been proven. The treatment mainly focuses on maintaining balance in the fluids and electrolytes, nutritional support, and oxygen therapy for this vulnerable population.

本综述旨在了解小儿严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染后的冠状病毒病2019 (COVID-19)特征。据文献报道,新冠肺炎在儿童中的发病率为1-5%。然而,儿童感染新变种病毒的发生率较高。最常见的症状是发烧和呼吸症状。儿童感染COVID-19的严重程度较轻,死亡率较低,这与儿童接触较少、免疫系统不成熟以及血管紧张素转换酶2 (ACE2)的不同特征有关,ACE2是病毒入侵宿主细胞的重要受体。重症患儿出现合并感染、脑炎、多系统炎症综合征、多器官功能衰竭等并发症。最常见的实验室数据是降钙素原升高。炎症因子增强和淋巴细胞减少症在该人群中较少见。CT表现以磨玻璃影、肺实变、细网影、小结节多见。虽然有些儿童入住ICU,但很少有机械通气的报道。从母亲到孩子的垂直宫内传播尚未得到证实。治疗的重点是维持体液和电解质的平衡、营养支持和对这一脆弱人群的氧气治疗。
{"title":"COVID-19 in Pediatric Patients: An update on Features and Treatment Options.","authors":"Zahra Soheilirad,&nbsp;Pegah Karimian,&nbsp;Motahare Aghajani Delvar","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This review aimed to identify the features of coronavirus disease 2019 (COVID-19) in pediatric patients after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. According to the literature, the incidence of COVID-19 was reported to be 1-5% among children. However, the incidence of infection with the new variant of the virus is higher in children. The most common features were fever and respiratory manifestation. The milder severity and lower mortality of COVID-19 among children are related to their less contact, immature immune system, and different features of angiotensin-converting enzyme 2 (ACE2), an important receptor of the virus to invade the host cells. Several complications were observed in severe pediatric patients, such as coinfections, encephalitis, multisystem inflammatory syndrome, and multiorgan failure. The most frequent laboratory data were the procalcitonin elevation. The enhanced inflammatory factors and lymphocytopenia were less common among this population. In the CT findings, the ground-glass opacities, pulmonary consolidation, fine mesh shadow, and tiny nodules were most common. While some children were admitted to the ICU, mechanical ventilation was rarely reported. The vertical intrauterine transmission from mother to child has not been proven. The treatment mainly focuses on maintaining balance in the fluids and electrolytes, nutritional support, and oxygen therapy for this vulnerable population.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2a/48/Tanaffos-21-283.PMC10073955.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9271560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Ratio of Height to Rhinion-Mentum Distance as a Predictive Tool for Difficult Tracheal Intubation. 评估鼻尖高度与鼻尖距离之比作为气管插管困难的预测工具。
Q3 Medicine Pub Date : 2022-03-01
Masoud Nashibi, Zahid Husain Khan, Kamran Mottaghi

Background: Difficult Intubation (DI) is a constant concern for anesthesiologists and being able to predict it will improve patient safety. Different tests have been presented in anesthesiology practice to increase the accuracy of the DI prediction. Since there is no single sensitive and specific test, most of the practitioners use a combination of them. Here we report a new and novel index of ratio of height to rhinion-mentum distance (RHRMD) to improve the prediction.

Materials and methods: Four hundred adult patients' candidate for elective surgery were enrolled into the study. Initially, patients' data such as weight, height and rhinion-mentum distance (RMD) were recorded by the first anesthesiologist. After anesthesia induction, the second anesthesiologist performed laryngoscopy and recorded the Cormack-Lehane (CL) score. CL score III or higher was considered as DI. Finally, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for RHRMD was calculated.

Results: DI was reported in 7.75% of patients. RHRMD is related with CL grade: as the former increased, the latter decreased. RHRMD with cut-off point 25.4 has 90.6% sensitivity, 29.9% specificity, 10.1% PPV and 97.3% NPV in predicting DI.

Conclusion: RHRMD with 90.6% sensitivity and 97.3% NPV could be a valuable tool for prediction of DI.

背景:插管困难(DI)一直是麻醉师关注的问题,能够预测它将提高患者的安全性。麻醉学实践中提出了不同的测试来提高DI预测的准确性。由于没有单一的敏感和特定的测试,大多数从业者使用他们的组合。本文报道了一种新的高度与鼻动量距离之比(RHRMD)指标,以改进预测。材料与方法:选取400例拟择期手术的成年患者作为研究对象。最初,患者的体重、身高、鼻颏距(RMD)等数据由第一位麻醉师记录。麻醉诱导后,第二麻醉师行喉镜检查并记录Cormack-Lehane (CL)评分。CL评分III及以上为DI。最后计算RHRMD的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。结果:7.75%的患者报告了DI。RHRMD与CL分级相关,前者升高,后者降低。截断点为25.4的RHRMD预测DI的敏感性为90.6%,特异性为29.9%,PPV为10.1%,NPV为97.3%。结论:RHRMD的灵敏度为90.6%,NPV为97.3%,可作为预测DI的有效工具。
{"title":"Assessment of Ratio of Height to Rhinion-Mentum Distance as a Predictive Tool for Difficult Tracheal Intubation.","authors":"Masoud Nashibi,&nbsp;Zahid Husain Khan,&nbsp;Kamran Mottaghi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Difficult Intubation (DI) is a constant concern for anesthesiologists and being able to predict it will improve patient safety. Different tests have been presented in anesthesiology practice to increase the accuracy of the DI prediction. Since there is no single sensitive and specific test, most of the practitioners use a combination of them. Here we report a new and novel index of ratio of height to rhinion-mentum distance (RHRMD) to improve the prediction.</p><p><strong>Materials and methods: </strong>Four hundred adult patients' candidate for elective surgery were enrolled into the study. Initially, patients' data such as weight, height and rhinion-mentum distance (RMD) were recorded by the first anesthesiologist. After anesthesia induction, the second anesthesiologist performed laryngoscopy and recorded the Cormack-Lehane (CL) score. CL score III or higher was considered as DI. Finally, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for RHRMD was calculated.</p><p><strong>Results: </strong>DI was reported in 7.75% of patients. RHRMD is related with CL grade: as the former increased, the latter decreased. RHRMD with cut-off point 25.4 has 90.6% sensitivity, 29.9% specificity, 10.1% PPV and 97.3% NPV in predicting DI.</p><p><strong>Conclusion: </strong>RHRMD with 90.6% sensitivity and 97.3% NPV could be a valuable tool for prediction of DI.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e9/e7/Tanaffos-21-362.PMC10073948.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9259195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Nebulized Lidocaine and Intratracheally Injected (Spray-as-you-go) Lidocaine in Pain and Cough Reduction during Bronchoscopy. 雾化利多卡因与气管内注射(随用随喷)利多卡因在支气管镜检查中减轻疼痛和咳嗽的比较。
Q3 Medicine Pub Date : 2022-03-01
Saeid Islamitabar, Mohammad Gholizadeh, Mohammad Hasan Rakhshani, Asghar Kazemzadeh, MoosaalReza Tadayonfar

Background: Patients undergoing bronchoscopy often suffer from pain, coughing, and suffocation. Therefore, lidocaine is prescribed through various methods to induce local anesthesia. This study aimed to compare nebulized lidocaine and intratracheally injected lidocaine in pain and cough reduction during bronchoscopy.

Materials and methods: This clinical trial was performed on 96 patients, divided into two groups of intervention (receiving lidocaine via a nebulizer before bronchoscopy) and control (receiving lidocaine through the working channel of bronchoscope). Then, the patients᾽ cough frequency was recorded during the procedure, and the pain level was measured using a numerical rating scale at the end of the procedure. The data were analyzed with SPSS software (version 16) using the chi-square and Fisher's exact tests. Moreover, the linear and Poisson regression tests were applied to analyze the main variables in this study.

Results: There was no significant difference between the two groups regarding demographic characteristics (P>0.05). Moreover, the linear regression test revealed that the intervention (nebulized lidocaine) group had significantly lower pain scores (1.54±0.08) than the control (intratracheally injected lidocaine) group (2.5±0.26) (P=0.013). In addition, the Poisson regression test showed a statistically significant difference between the intervention (35.22±2.93) and control (48.85±5.96) groups in terms of cough frequency (P<0.0001).

Conclusion: This study indicated that nebulized lidocaine has higher efficacy in reducing the patients᾽ pain and cough during bronchoscopy than intratracheally injected lidocaine.

背景:接受支气管镜检查的患者经常出现疼痛、咳嗽和窒息。因此,利多卡因通过各种方法开处方来诱导局部麻醉。本研究旨在比较雾化利多卡因和气管内注射利多卡因在支气管镜检查中减轻疼痛和咳嗽的效果。材料与方法:本临床试验共96例患者,分为干预组(支气管镜检查前雾化吸入利多卡因组)和对照组(支气管镜工作通道吸入利多卡因组)。然后在治疗过程中记录患者的咳嗽频率,并在治疗结束时用数值评定量表测量疼痛程度。使用SPSS软件(version 16)进行数据分析,采用卡方检验和Fisher精确检验。采用线性回归检验和泊松回归检验对主要变量进行分析。结果:两组患者人口学特征比较差异无统计学意义(P>0.05)。线性回归检验显示,干预组(雾化利多卡因组)疼痛评分(1.54±0.08)明显低于对照组(气管内注射利多卡因组)(2.5±0.26)(P=0.013)。泊松回归检验显示,干预组(35.22±2.93)与对照组(48.85±5.96)咳嗽频率差异有统计学意义(p)。结论:本研究表明,雾化利多卡因在缓解患者支气管镜检查时的疼痛和咳嗽方面比气管内注射利多卡因有更高的疗效。
{"title":"Comparison of Nebulized Lidocaine and Intratracheally Injected (Spray-as-you-go) Lidocaine in Pain and Cough Reduction during Bronchoscopy.","authors":"Saeid Islamitabar,&nbsp;Mohammad Gholizadeh,&nbsp;Mohammad Hasan Rakhshani,&nbsp;Asghar Kazemzadeh,&nbsp;MoosaalReza Tadayonfar","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Patients undergoing bronchoscopy often suffer from pain, coughing, and suffocation. Therefore, lidocaine is prescribed through various methods to induce local anesthesia. This study aimed to compare nebulized lidocaine and intratracheally injected lidocaine in pain and cough reduction during bronchoscopy.</p><p><strong>Materials and methods: </strong>This clinical trial was performed on 96 patients, divided into two groups of intervention (receiving lidocaine via a nebulizer before bronchoscopy) and control (receiving lidocaine through the working channel of bronchoscope). Then, the patients᾽ cough frequency was recorded during the procedure, and the pain level was measured using a numerical rating scale at the end of the procedure. The data were analyzed with SPSS software (version 16) using the chi-square and Fisher's exact tests. Moreover, the linear and Poisson regression tests were applied to analyze the main variables in this study.</p><p><strong>Results: </strong>There was no significant difference between the two groups regarding demographic characteristics (P>0.05). Moreover, the linear regression test revealed that the intervention (nebulized lidocaine) group had significantly lower pain scores (1.54±0.08) than the control (intratracheally injected lidocaine) group (2.5±0.26) (P=0.013). In addition, the Poisson regression test showed a statistically significant difference between the intervention (35.22±2.93) and control (48.85±5.96) groups in terms of cough frequency (P<0.0001).</p><p><strong>Conclusion: </strong>This study indicated that nebulized lidocaine has higher efficacy in reducing the patients᾽ pain and cough during bronchoscopy than intratracheally injected lidocaine.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/c7/Tanaffos-21-348.PMC10073944.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9252999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Cigarette Smoking and its Related Factors among Students in Iran: A Meta-Analysis. 伊朗学生吸烟率及其相关因素:一项荟萃分析
Q3 Medicine Pub Date : 2022-03-01
Marzieh Aslani, Mahboubeh Nazari, Hamidreza Jamaati, Omid Naseri, Sholeh Saedmoucheshi, Prashant Kumar Singh, Reza Ghanei Gheshlagh

Background: Smoking is a preventable cause of morbidity and mortality with an increasing prevalence in developing countries. The present systematic review and meta-analysis aimed to estimate the prevalence of smoking among college and high school students in Iran.

Materials and methods: Databases of Scopus, PubMed, Web of Science, Google Scholar, SID, and MagIran were searched with no time limitation. Observational studies published in Persian or English were included in the analysis. Time frame of the searches was from inception until 1 January 2021. The data was analyzed using random effects model, subgroup analysis, and meta-regression analysis. Heterogeneity among studies was examined using Cochran's Q test and I2 statistic.

Results: A total of 63 articles with a sample size of 58742 were analyzed. The pooled smoking prevalence was found to be 13.56% (95% CI: 11.65-15.47). There was a significant increase in the prevalence of smoking among female students between 1998 and 2020. Regions 1 of Iran had the highest prevalence rates of smoking (Provinces of Alborz, Tehran, Qazvin, Mazandaran, Semnan, Golestan, and Qom). Smoking was more prevalent among college students (15.62%, 95% CI: 13.14-18.10) than in high school students (9.77%, 95% CI: 7.19-12.35).

Conclusion: Given the relatively high prevalence of smoking among Iranian college and high school students, it is necessary to inform them about the harmful effects of smoking through training programs.

背景:吸烟是一种可预防的发病和死亡原因,在发展中国家的患病率越来越高。本系统综述和荟萃分析旨在估计伊朗大学生和高中生吸烟的流行程度。材料和方法:检索Scopus、PubMed、Web of Science、Google Scholar、SID、MagIran等数据库,无时间限制。以波斯语或英语发表的观察性研究被纳入分析。搜索的时间范围从开始到2021年1月1日。采用随机效应模型、亚组分析和元回归分析对数据进行分析。采用Cochran’s Q检验和I2统计量检验各研究间的异质性。结果:共分析63篇文献,样本量58742。总吸烟率为13.56% (95% CI: 11.65-15.47)。1998年至2020年间,女学生的吸烟率显著上升。伊朗第一地区的吸烟率最高(阿尔博尔兹省、德黑兰省、加兹温省、马赞达兰省、塞姆南省、戈列斯坦省和库姆省)。吸烟在大学生中(15.62%,95% CI: 13.14-18.10)比在高中生中(9.77%,95% CI: 7.19-12.35)更为普遍。结论:鉴于伊朗大学生和高中生吸烟率相对较高,有必要通过培训项目告知他们吸烟的有害影响。
{"title":"Prevalence of Cigarette Smoking and its Related Factors among Students in Iran: A Meta-Analysis.","authors":"Marzieh Aslani,&nbsp;Mahboubeh Nazari,&nbsp;Hamidreza Jamaati,&nbsp;Omid Naseri,&nbsp;Sholeh Saedmoucheshi,&nbsp;Prashant Kumar Singh,&nbsp;Reza Ghanei Gheshlagh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Smoking is a preventable cause of morbidity and mortality with an increasing prevalence in developing countries. The present systematic review and meta-analysis aimed to estimate the prevalence of smoking among college and high school students in Iran.</p><p><strong>Materials and methods: </strong>Databases of Scopus, PubMed, Web of Science, Google Scholar, SID, and MagIran were searched with no time limitation. Observational studies published in Persian or English were included in the analysis. Time frame of the searches was from inception until 1 January 2021. The data was analyzed using random effects model, subgroup analysis, and meta-regression analysis. Heterogeneity among studies was examined using Cochran's Q test and I<sup>2</sup> statistic.</p><p><strong>Results: </strong>A total of 63 articles with a sample size of 58742 were analyzed. The pooled smoking prevalence was found to be 13.56% (95% CI: 11.65-15.47). There was a significant increase in the prevalence of smoking among female students between 1998 and 2020. Regions 1 of Iran had the highest prevalence rates of smoking (Provinces of Alborz, Tehran, Qazvin, Mazandaran, Semnan, Golestan, and Qom). Smoking was more prevalent among college students (15.62%, 95% CI: 13.14-18.10) than in high school students (9.77%, 95% CI: 7.19-12.35).</p><p><strong>Conclusion: </strong>Given the relatively high prevalence of smoking among Iranian college and high school students, it is necessary to inform them about the harmful effects of smoking through training programs.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ed/0d/Tanaffos-21-271.PMC10073949.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9271555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spectrum and Burden of Influenza Infection: An Approach to Identify Predictors of Morbidity and Mortality Rate from the Patients of the Northwest of Iran. 流感感染的频谱和负担:确定伊朗西北部患者发病率和死亡率预测因素的方法。
Q3 Medicine Pub Date : 2022-03-01
Amin Daei Sorkhabi, Aila Sarkesh, Nader Mohammadzadeh, Parisa Shiri Aghbash, Hossein Bannazadeh Baghi

Background: The objective of this research is to analyze influenza-induced complications, symptoms, and the interaction of morbidity and mortality rates in hospitalized influenza cases based on age-sex dispersion, influenza virus subtype, prescribed medications, and underlying conditions.

Materials and methods: We performed this retrospective study using a dataset of 10,517 hospitalized individuals, including 3,101 laboratory-confirmed influenza cases from patients of all ages who had attended hospitals in the Northwest of Iran due to respiratory complications.

Results: The most prevalent strain which circulated annually was influenza A/H3N2. In contrast to previous studies, our findings suggested that influenza A/H1N1 has the highest mortality rate and the most severe complications.Regardless of virus type/subtype, the most susceptible age group for influenza was 0-9 years old in both males and females. Meanwhile the high-risk age group among males was 50-59 years old and among females were over 80 age group (mortality rate ≈ 20%). Chronic obstructive pulmonary disease (COPD) (32%) and cardiovascular disease (CVD) (30%) were the most prevalent active underlying diseases among the patients who died, with the latter being more prevalent in males over the age of 70. Patients with a history of chemotherapy had the highest mortality rate. Patients who were prescribed a combination of antibiotics and antivirals had better outcomes with lowest mortality rate.

Conclusion: Our findings demonstrated that annual influenza seasons are often marked by changes in influenza types and subtypes, with variations in the severity. Development of a standardized set of arrays that best correspond with infections, can be useful in guiding diagnostic and therapeutic decisions.

背景:本研究的目的是分析流感引起的并发症、症状,以及基于年龄、性别分布、流感病毒亚型、处方药物和基础条件的住院流感病例发病率和死亡率的相互作用。材料和方法:我们使用10517名住院患者的数据集进行了这项回顾性研究,其中包括3101例实验室确诊的流感病例,这些病例来自伊朗西北部因呼吸道并发症住院的所有年龄段的患者。结果:年流行株以甲型H3N2流感为主。与以往的研究相反,我们的研究结果表明,甲型H1N1流感的死亡率最高,并发症也最严重。无论病毒类型/亚型如何,最易感染流感的年龄组是0-9岁的男性和女性。男性为50 ~ 59岁,女性为80岁以上(死亡率≈20%)。慢性阻塞性肺疾病(COPD)(32%)和心血管疾病(CVD)(30%)是死亡患者中最普遍的活动性基础疾病,后者在70岁以上的男性中更为普遍。有化疗史的患者死亡率最高。同时服用抗生素和抗病毒药物的患者治疗效果更好,死亡率最低。结论:我们的研究结果表明,每年的流感季节通常以流感类型和亚型的变化以及严重程度的变化为特征。开发一套最符合感染的标准化阵列,可用于指导诊断和治疗决策。
{"title":"Spectrum and Burden of Influenza Infection: An Approach to Identify Predictors of Morbidity and Mortality Rate from the Patients of the Northwest of Iran.","authors":"Amin Daei Sorkhabi,&nbsp;Aila Sarkesh,&nbsp;Nader Mohammadzadeh,&nbsp;Parisa Shiri Aghbash,&nbsp;Hossein Bannazadeh Baghi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The objective of this research is to analyze influenza-induced complications, symptoms, and the interaction of morbidity and mortality rates in hospitalized influenza cases based on age-sex dispersion, influenza virus subtype, prescribed medications, and underlying conditions.</p><p><strong>Materials and methods: </strong>We performed this retrospective study using a dataset of 10,517 hospitalized individuals, including 3,101 laboratory-confirmed influenza cases from patients of all ages who had attended hospitals in the Northwest of Iran due to respiratory complications.</p><p><strong>Results: </strong>The most prevalent strain which circulated annually was influenza A/H3N2. In contrast to previous studies, our findings suggested that influenza A/H1N1 has the highest mortality rate and the most severe complications.Regardless of virus type/subtype, the most susceptible age group for influenza was 0-9 years old in both males and females. Meanwhile the high-risk age group among males was 50-59 years old and among females were over 80 age group (mortality rate ≈ 20%). Chronic obstructive pulmonary disease (COPD) (32%) and cardiovascular disease (CVD) (30%) were the most prevalent active underlying diseases among the patients who died, with the latter being more prevalent in males over the age of 70. Patients with a history of chemotherapy had the highest mortality rate. Patients who were prescribed a combination of antibiotics and antivirals had better outcomes with lowest mortality rate.</p><p><strong>Conclusion: </strong>Our findings demonstrated that annual influenza seasons are often marked by changes in influenza types and subtypes, with variations in the severity. Development of a standardized set of arrays that best correspond with infections, can be useful in guiding diagnostic and therapeutic decisions.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/ef/Tanaffos-21-317.PMC10073956.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9271558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Family Presence on the Success of Weaning in Intensive Care Units. 家庭存在对重症监护病房成功脱机的影响。
Q3 Medicine Pub Date : 2022-03-01
Elham Arvinpour, Abdolali Shariati, Neda Sayadi, Mohammad Hosein Haghighi

Background: Weaning of the patient from mechanical ventilator is one of important stages of treatment in patients undergoing mechanical ventilation. Therefore, this study was done to determine the effect of family presence on weaning success in patients admitted to intensive care units (ICUs).

Materials and methods: The present interventional quasi-experimental study was performed on 154 patients undergoing mechanical ventilation who were selected through available sampling method and based on inclusion criteria and were randomly divided into intervention and control groups. For the intervention group, the presence of one of the family members was used in process of weaning from the mechanical ventilator. A questionnaire of patients' demographic information, family satisfaction of patients admitted to ICU, and a checklist of recording the patient's vital signs were used to collect the required information.

Results: Based on the results, After the intervention, the patients in the intervention group were in a better condition than the control group in terms of vital signs, time spent for intubation and number of re-intubation, as well as family satisfaction (P<0.05).

Conclusion: The results showed that the presence of family in the process of weaning of patients admitted to the intensive care unit is effective in improving vital signs and physiological indicators and reduces the time spent for intubation and the number of re-intubation in these patients while promoting family satisfaction. Therefore, the use of this method can be used in coordination with members of the treatment team to help patients admitted to the intensive care unit.

背景:患者脱离机械呼吸机是机械通气患者治疗的重要阶段之一。因此,本研究旨在确定家庭存在对入住重症监护病房(icu)患者断奶成功的影响。材料与方法:采用现有的抽样方法,根据纳入标准选取154例机械通气患者,随机分为干预组和对照组,进行介入准实验研究。干预组在患者脱离机械呼吸机的过程中,由其中一名家庭成员在场。采用患者人口统计资料问卷、ICU住院患者家属满意度问卷、患者生命体征记录清单收集所需信息。结果:干预后,干预组患者在生命体征、插管时间、再插管次数、家属满意度等方面均优于对照组(p)。结果表明,在重症监护病房入住患者的脱机过程中,家属的存在对改善患者的生命体征和生理指标是有效的,减少了患者的插管时间和再插管次数,同时提高了家属的满意度。因此,使用这种方法可以配合治疗小组成员帮助患者入住重症监护病房。
{"title":"Effect of Family Presence on the Success of Weaning in Intensive Care Units.","authors":"Elham Arvinpour,&nbsp;Abdolali Shariati,&nbsp;Neda Sayadi,&nbsp;Mohammad Hosein Haghighi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Weaning of the patient from mechanical ventilator is one of important stages of treatment in patients undergoing mechanical ventilation. Therefore, this study was done to determine the effect of family presence on weaning success in patients admitted to intensive care units (ICUs).</p><p><strong>Materials and methods: </strong>The present interventional quasi-experimental study was performed on 154 patients undergoing mechanical ventilation who were selected through available sampling method and based on inclusion criteria and were randomly divided into intervention and control groups. For the intervention group, the presence of one of the family members was used in process of weaning from the mechanical ventilator. A questionnaire of patients' demographic information, family satisfaction of patients admitted to ICU, and a checklist of recording the patient's vital signs were used to collect the required information.</p><p><strong>Results: </strong>Based on the results, After the intervention, the patients in the intervention group were in a better condition than the control group in terms of vital signs, time spent for intubation and number of re-intubation, as well as family satisfaction (P<0.05).</p><p><strong>Conclusion: </strong>The results showed that the presence of family in the process of weaning of patients admitted to the intensive care unit is effective in improving vital signs and physiological indicators and reduces the time spent for intubation and the number of re-intubation in these patients while promoting family satisfaction. Therefore, the use of this method can be used in coordination with members of the treatment team to help patients admitted to the intensive care unit.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/78/e0/Tanaffos-21-367.PMC10073960.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9253003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients? 慢性阻塞性肺疾病伴频繁加重表型:这些患者有何不同?
Q3 Medicine Pub Date : 2022-03-01
Berat Uslu, Askin Gülsen, Burcu Arpinar Yigitbas

Background: Acute exacerbation events, which can develop during the natural course of chronic obstructive pulmonary disease (COPD) can lead to worsening quality of life, increased hospital costs, and higher rates of morbidity and mortality. In recent years, individuals at heightened risk of COPD exacerbations have been said to display a so-called "frequent exacerbator (FE)" phenotype, defined as having two or more exacerbation events (or ≥ 1 exacerbation with a hospitalization) within 1 year.

Materials and methods: We conducted a retrospective study involving 299 patients with COPD. Patients were divided into 2 groups as non-exacerbator phenotype (group-1, n=195) and FE phenotype (group-2, n=104).

Results: FE phenotype was identified in 35.1% of patients. There were no significant differences between these two phenotypes in terms of gender, smoking status, or leukocyte count. However, FEs were found to be older (p=0.04), with more frequent detection of emphysema (p=0.02) and lower eosinophil levels (p=0.02). FEs also demonstrated worse pulmonary function parameters.

Conclusion: COPD patients with the FE phenotype likely require a different treatment algorithm due to differing clinical features such as poorer respiratory function, lower eosinophil levels, and more frequent emphysema.

背景:慢性阻塞性肺疾病(COPD)自然病程中发生的急性加重事件可导致生活质量恶化、住院费用增加、发病率和死亡率升高。近年来,COPD加重风险增高的个体被认为表现出所谓的“频繁加重(FE)”表型,定义为在1年内发生两次或两次以上加重事件(或≥1次加重并住院)。材料和方法:我们对299例COPD患者进行了回顾性研究。将患者分为非加重型(组1,n=195)和加重型(组2,n=104) 2组。结果:35.1%的患者存在FE表型。这两种表型在性别、吸烟状况或白细胞计数方面没有显著差异。然而,FEs年龄更大(p=0.04),肺气肿检测频率更高(p=0.02),嗜酸性粒细胞水平更低(p=0.02)。FEs还表现出更差的肺功能参数。结论:FE表型的COPD患者可能需要不同的治疗方法,因为不同的临床特征,如呼吸功能较差,嗜酸性粒细胞水平较低,肺气肿更频繁。
{"title":"Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?","authors":"Berat Uslu,&nbsp;Askin Gülsen,&nbsp;Burcu Arpinar Yigitbas","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Acute exacerbation events, which can develop during the natural course of chronic obstructive pulmonary disease (COPD) can lead to worsening quality of life, increased hospital costs, and higher rates of morbidity and mortality. In recent years, individuals at heightened risk of COPD exacerbations have been said to display a so-called \"frequent exacerbator (FE)\" phenotype, defined as having two or more exacerbation events (or ≥ 1 exacerbation with a hospitalization) within 1 year.</p><p><strong>Materials and methods: </strong>We conducted a retrospective study involving 299 patients with COPD. Patients were divided into 2 groups as non-exacerbator phenotype (group-1, n=195) and FE phenotype (group-2, n=104).</p><p><strong>Results: </strong>FE phenotype was identified in 35.1% of patients. There were no significant differences between these two phenotypes in terms of gender, smoking status, or leukocyte count. However, FEs were found to be older (p=0.04), with more frequent detection of emphysema (p=0.02) and lower eosinophil levels (p=0.02). FEs also demonstrated worse pulmonary function parameters.</p><p><strong>Conclusion: </strong>COPD patients with the FE phenotype likely require a different treatment algorithm due to differing clinical features such as poorer respiratory function, lower eosinophil levels, and more frequent emphysema.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c6/f1/Tanaffos-21-307.PMC10073954.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9253002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Flexible Fiberoptic Bronchoscopy in the Diagnosis and Treatment of Pediatric Airway Foreign Bodies: A 5-Year Experience at a Tertiary Care Hospital in Iran. 柔性纤维支气管镜在诊断和治疗小儿气道异物中的作用:伊朗一家三级医院的5年经验
Q3 Medicine Pub Date : 2022-03-01
Danial Turk, Mohammad Ashkan Moslehi, Hamidreza Hosseinpour

Background: Foreign body aspiration can be a life-threatening incidence amongst children. The aim of this study was to evaluate the usefulness and outcomes of foreign body removal with emphasis on accuracy of flexible fiberoptic bronchoscopy and the predictors of post-procedure complications in children.

Materials and methods: Records of patients who had undergone flexible fiberoptic bronchoscopy for foreign body extraction in Namazi Hospital affiliated to Shiraz University of Medical Sciences from 2012 to 2017 were retrospectively reviewed.

Results: 109 patients in whom foreign body were detected by flexible fiberoptic bronchoscopy were enrolled. The patients' age range was between 10 days to 16 years, with the male predominance and the peak incidence amongst toddlers aged 1 to 2 years. The majority of foreign body were situated in the left main bronchus (22.9%). Coughing (37.5%) and chocking (20.8%) were the most commonly recorded symptoms. Hyperinflation (63.5%) and lung collapse (19.2%) were the most radiological findings. The duration of the procedure for 50.5% of the patients was 5-8 minutes. No complications were recorded during the flexible fiberoptic bronchoscopy procedure. Ninety-five percent of the patients had more than one visit before their admission for bronchoscopy with incorrect diagnosis of asthma/reactive airway disease and pneumonia, 74 and 20%, respectively.

Conclusion: Although rigid bronchoscopy is still considered as the gold standard and preferred method in managing the airways foreign bodies, flexible fiberoptic bronchoscopy also can be used as an effective diagnostic and therapeutic tool with high success.

背景:儿童异物吸入会危及生命。本研究的目的是评估异物清除术的有效性和结果,重点是软性纤维支气管镜检查的准确性和儿童术后并发症的预测因素。材料与方法:回顾性分析设拉子医科大学附属Namazi医院2012 - 2017年行柔性纤维支气管镜异物取出术的患者记录。结果:纳入109例经纤维支气管镜检查出异物的患者。患者年龄在10天至16岁之间,以男性为主,发病高峰为1 ~ 2岁幼儿。大部分异物位于左主支气管(22.9%)。咳嗽(37.5%)和窒息(20.8%)是最常见的记录症状。恶性通货膨胀(63.5%)和肺萎陷(19.2%)是最常见的影像学表现。50.5%的患者手术时间为5-8分钟。柔性纤维支气管镜检查过程中无并发症记录。95%的患者在入院前进行了一次以上的支气管镜检查,误诊为哮喘/反应性气道疾病和肺炎,分别为74%和20%。结论:虽然刚性支气管镜仍被认为是处理气道异物的金标准和首选方法,但柔性纤维支气管镜也可作为一种有效的诊断和治疗工具,成功率高。
{"title":"Role of Flexible Fiberoptic Bronchoscopy in the Diagnosis and Treatment of Pediatric Airway Foreign Bodies: A 5-Year Experience at a Tertiary Care Hospital in Iran.","authors":"Danial Turk,&nbsp;Mohammad Ashkan Moslehi,&nbsp;Hamidreza Hosseinpour","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Foreign body aspiration can be a life-threatening incidence amongst children. The aim of this study was to evaluate the usefulness and outcomes of foreign body removal with emphasis on accuracy of flexible fiberoptic bronchoscopy and the predictors of post-procedure complications in children.</p><p><strong>Materials and methods: </strong>Records of patients who had undergone flexible fiberoptic bronchoscopy for foreign body extraction in Namazi Hospital affiliated to Shiraz University of Medical Sciences from 2012 to 2017 were retrospectively reviewed.</p><p><strong>Results: </strong>109 patients in whom foreign body were detected by flexible fiberoptic bronchoscopy were enrolled. The patients' age range was between 10 days to 16 years, with the male predominance and the peak incidence amongst toddlers aged 1 to 2 years. The majority of foreign body were situated in the left main bronchus (22.9%). Coughing (37.5%) and chocking (20.8%) were the most commonly recorded symptoms. Hyperinflation (63.5%) and lung collapse (19.2%) were the most radiological findings. The duration of the procedure for 50.5% of the patients was 5-8 minutes. No complications were recorded during the flexible fiberoptic bronchoscopy procedure. Ninety-five percent of the patients had more than one visit before their admission for bronchoscopy with incorrect diagnosis of asthma/reactive airway disease and pneumonia, 74 and 20%, respectively.</p><p><strong>Conclusion: </strong>Although rigid bronchoscopy is still considered as the gold standard and preferred method in managing the airways foreign bodies, flexible fiberoptic bronchoscopy also can be used as an effective diagnostic and therapeutic tool with high success.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/71/b4/Tanaffos-21-354.PMC10073951.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9252997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physiopathological Mechanisms Involved in the Progression of Pulmonary Fibrosis: A Systematic Review. 参与肺纤维化进展的生理病理机制:系统综述。
Q3 Medicine Pub Date : 2022-03-01
Sana Bahri, Saloua Jameleddine

Idiopathic Pulmonary Fibrosis (IPF) is a lung disease characterized by formation of fibroblast foci and honeycomb lesions in the pulmonary parenchyma. The physiopathological mechanisms involved in the development of fibrosis and architectural disorganization are still imperfectly elucidated. In fact, lesion formation is irreversible and no treatment, to date, has been shown to be effective (30% of patients die within 5 years of the onset of the disease). The long-held concept of chronic inflammation leading to fibrosis is still controversial. Indeed, recent data suggest that the physiopathology of this disease is the product of fibroblast dysfunction rather than the result of an inflammatory imbalance. This concept supports the parallel involvement of three main factors: epithelial damage, angiogenesis and oxidative stress. In this review we highlighted the different factors and the ethiopathogenic pathways involved in the fibrotic process, in order to increase our understanding of the mechanisms involved in this pulmonary pathology.

特发性肺纤维化(IPF)是一种肺部疾病,其特征是在肺实质中形成成纤维细胞灶和蜂窝状病变。参与纤维化和结构紊乱发展的生理病理机制仍未完全阐明。事实上,病变的形成是不可逆的,迄今为止没有任何治疗被证明是有效的(30%的患者在发病后5年内死亡)。长期以来,慢性炎症导致纤维化的概念仍然存在争议。事实上,最近的数据表明,这种疾病的生理病理是成纤维细胞功能障碍的产物,而不是炎症不平衡的结果。这一概念支持三个主要因素的平行参与:上皮损伤、血管生成和氧化应激。在这篇综述中,我们强调了纤维化过程中涉及的不同因素和埃塞俄比亚致病途径,以增加我们对这种肺部病理机制的理解。
{"title":"Physiopathological Mechanisms Involved in the Progression of Pulmonary Fibrosis: A Systematic Review.","authors":"Sana Bahri,&nbsp;Saloua Jameleddine","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Idiopathic Pulmonary Fibrosis (IPF) is a lung disease characterized by formation of fibroblast foci and honeycomb lesions in the pulmonary parenchyma. The physiopathological mechanisms involved in the development of fibrosis and architectural disorganization are still imperfectly elucidated. In fact, lesion formation is irreversible and no treatment, to date, has been shown to be effective (30% of patients die within 5 years of the onset of the disease). The long-held concept of chronic inflammation leading to fibrosis is still controversial. Indeed, recent data suggest that the physiopathology of this disease is the product of fibroblast dysfunction rather than the result of an inflammatory imbalance. This concept supports the parallel involvement of three main factors: epithelial damage, angiogenesis and oxidative stress. In this review we highlighted the different factors and the ethiopathogenic pathways involved in the fibrotic process, in order to increase our understanding of the mechanisms involved in this pulmonary pathology.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/29/Tanaffos-21-263.PMC10073959.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9271561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung Adenocarcinoma. 肺腺癌患者表皮生长因子受体对酪氨酸激酶抑制剂的T790M和获得性耐药
Q3 Medicine Pub Date : 2022-03-01
Hanifeh Mirtavoos-Mahyari, Azizollah Abbasi Dezfouli, Zahra Esfahani-Monfared, Adnan Khosravi, Sharareh Seifi, Kambiz Sheikhy

Background: Activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to tyrosine kinase inhibitors (TKIs), but responses to TKIs is not permanent and drug resistance eventually happens for almost all patients. Subsequent studies found different resistance mechanisms, among which (EGFR) T790M mutation is the most important mechanism of TKI treatment failure. Using cell-free DNA (cfDNA) is a new way for diagnosing resistance mutations in EGFR. The aim of present study is to determine cfDNA-identified recurrence mutation rate and their association with clinical outcome in lung Adenocarcinoma patients.

Materials and methods: Patients who were diagnosed with metastatic adenocarcinoma of the lung and acquired resistance to TKIs were enrolled. The incidence of T790M positivity, overall survival (OS) and median duration of TKI treatment before progression was calculated. Polymerase chain reaction (PCR) and sequencing were used to identify the T790M mutation in cfDNA.

Results: The incidence of T790M mutations was higher in men, younger cases (<59 years), in patients with L858R primary mutation and never smokers although they were not significantly different (P-values= 041, 0.316, 0.316 and 0.158, respectively). There was significant longer OS in the Del19 subgroup than the L858R subgroup (p = 0.014). In multivariable analysis, significant longer OS was associated with younger age (<59 years) and primary EGFR mutation exon 19 (P-values= 0.028 and 0.050, respectively).

Conclusion: T790M mutations frequency may differ by ethnicity, genetic factors and EGFR primary mutations. Detecting T790M mutations in plasma is considered as an indicator of treatment with third generation EGFR-TKIs.

背景:表皮生长因子受体(EGFR)的激活突变最初对酪氨酸激酶抑制剂(TKIs)有反应,但对TKIs的反应不是永久性的,几乎所有患者最终都会发生耐药性。后续研究发现了不同的耐药机制,其中(EGFR) T790M突变是TKI治疗失败的最重要机制。游离DNA (cfDNA)是诊断EGFR耐药突变的新方法。本研究的目的是确定cfdna鉴定的肺腺癌患者的复发突变率及其与临床转归的关系。材料和方法:入选诊断为肺转移性腺癌并获得TKIs耐药的患者。计算T790M阳性的发生率、TKI治疗进展前的总生存期(OS)和中位持续时间。采用聚合酶链反应(PCR)和测序技术鉴定cfDNA中T790M突变。结果:T790M突变在男性、年轻(L858R原发突变)和非吸烟者中发生率较高,但差异无统计学意义(p值分别为041、0.316、0.316、0.158)。Del19亚组的OS明显长于L858R亚组(p = 0.014)。在多变量分析中,明显较长的OS与较年轻的年龄相关(结论:T790M突变频率可能因种族、遗传因素和EGFR原发突变而异)。检测血浆中T790M突变被认为是第三代EGFR-TKIs治疗的指标。
{"title":"T790M and Acquired Resistance of Epidermal Growth Factor Receptor to Tyrosine Kinase Inhibitors in Patients with Lung Adenocarcinoma.","authors":"Hanifeh Mirtavoos-Mahyari,&nbsp;Azizollah Abbasi Dezfouli,&nbsp;Zahra Esfahani-Monfared,&nbsp;Adnan Khosravi,&nbsp;Sharareh Seifi,&nbsp;Kambiz Sheikhy","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Activating mutations in the epidermal growth factor receptor (EGFR) are initially responsive to tyrosine kinase inhibitors (TKIs), but responses to TKIs is not permanent and drug resistance eventually happens for almost all patients. Subsequent studies found different resistance mechanisms, among which (EGFR) T790M mutation is the most important mechanism of TKI treatment failure. Using cell-free DNA (cfDNA) is a new way for diagnosing resistance mutations in EGFR. The aim of present study is to determine cfDNA-identified recurrence mutation rate and their association with clinical outcome in lung Adenocarcinoma patients.</p><p><strong>Materials and methods: </strong>Patients who were diagnosed with metastatic adenocarcinoma of the lung and acquired resistance to TKIs were enrolled. The incidence of T790M positivity, overall survival (OS) and median duration of TKI treatment before progression was calculated. Polymerase chain reaction (PCR) and sequencing were used to identify the T790M mutation in cfDNA.</p><p><strong>Results: </strong>The incidence of T790M mutations was higher in men, younger cases (<59 years), in patients with <i>L858R</i> primary mutation and never smokers although they were not significantly different (P-values= 041, 0.316, 0.316 and 0.158, respectively). There was significant longer OS in the Del19 subgroup than the L858R subgroup (p = 0.014). In multivariable analysis, significant longer OS was associated with younger age (<59 years) and primary EGFR mutation exon 19 (P-values= 0.028 and 0.050, respectively).</p><p><strong>Conclusion: </strong>T790M mutations frequency may differ by ethnicity, genetic factors and EGFR primary mutations. Detecting T790M mutations in plasma is considered as an indicator of treatment with third generation EGFR-TKIs.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/99/Tanaffos-21-376.PMC10073946.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9276706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tanaffos
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1